Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.
abrdn Global Equity Impact A JETAX
- NAV / 1-Day Return 14.87 / +1.09 %
- Total Assets 45.5 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.150%
- Distribution Fee Level Average
- Share Class Type Front Load
- Category Global Large-Stock Growth
- Investment Style Large Growth
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 0.99%
- Turnover 31%
USD | NAV as of Mar 27, 2024 | 1-Day Return as of Mar 27, 2024, 10:19 PM GMT+0
Morningstar’s Analysis JETAX
Will JETAX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 41.1
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novo Nordisk A/S | 5.38 | 2.4 Mil | — |
Tetra Tech Inc | 4.64 | 2.1 Mil | Industrials |
UnitedHealth Group Inc | 4.59 | 2.0 Mil | Healthcare |
HDFC BANK LIMITED | 4.36 | 1.9 Mil | — |
RELX PLC | 4.26 | 1.9 Mil | Industrials |
ASML Holding NV | 4.14 | 1.8 Mil | Technology |
Merck & Co Inc | 4.01 | 1.8 Mil | Healthcare |
Usd Cash | 3.99 | 1.8 Mil | Cash and Equivalents |
NextEra Energy Inc | 3.36 | 1.5 Mil | Utilities |
Prologis Inc | 3.21 | 1.4 Mil | Real Estate |